In another study, IFNb treatment in MS patients was found to induce a specific over-expression of the proapoptotic and IFN inducible gene TRAIL only in the monocyte and granulocyte populations among nine peripheral blood cell subsets investigated [12]. Here, IFNB1 is linked to myeloid sarcoma.